Weeks after IPO, Peninsula drug maker lines up Asian cancer-fighting deal

The money represents only the second funding round in the company's 15 years......»»

The deal is the latest to add to Gilead's presence in cancer immunotherapy, an approach to treating cancer that harnesses the body's immune system......»»

The next-generation technology delivers "convertible" CARs, one of the hottest areas of cancer research......»»

Shares of gene-therapy companies shot up on Monday after Pfizer Inc. announced it would acquire cancer drug maker Array BioPharma Inc. in a deal worth up to $11.4 billion......»»

Shares in drug maker Daiichi Sankyo soared after AstraZeneca agreed to pay the Japanese company up to $6.9 billion as part of an agreement to develop and market a potentially "transformative" cancer treatment......»»

AstraZeneca Plc will pay up to $6.9 billion to work with Daiichi Sankyo Co Ltd on a hotly-tipped experimental treatment for breast cancer, in a direct challenge to the world's biggest cancer drug maker Roche......»»

Investors shaved nearly a third of the value off a South San Francisco drug maker's stock in after-hours trading Wednesday following an FDA advisory committee's split decision on approving the company's infection-fighting therapy. The panel voted unanim.....»»

The company was supposed to hear back from the FDA next week, but the agency made a rare ahead-of-schedule decision......»»

Agenus Inc. has signed its largest licensing deal ever for a tumor-fighting antibody that is still in preclinical development......»»

Caribou Biosciences Inc. — one of the first companies to spin Nobel Prize-winning UC Berkeley professor Jennifer Doudna's CRISPR genome-editing technology out of her lab — inked a deal with drug giant AbbVie Inc. to help develop an off-the-shel.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) read more.....»»

The company's co-founder, chairman and CEO is based in San Francisco, and it recently cut a deal with an East Bay biotech company......»»

S.....»»

Shares of Myovant Sciences soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant wi.....»»

Shares of Myovant Sciences soared 16% in premarket trade Monday, after its parent Sumitovant Biopharma said .....»»

Filing thousands of pages of data electronically from remote locations as employees sheltered in place against Covid-19, Myovant Sciences asked regulators Tuesday to quickly approve its once-a-day pill against prostate cancer. The Brisbane company a.....»»

Canadian authorities on Sunday reached a tentative deal with an indigenous group in the Pacific province of British Columbia that could end solidarity protests across Canada that have been blocking rail lines and roads for weeks......»»

Shares of Mallinckrodt PLC soared 15% in premarket trading Tuesday, after plunging 19% the previous session, after the drug maker announced a settlement agreement that would resolve all opioid-related cla.....»»

The Redwood City company raised $226 million in three venture rounds after its formation five years ago by Third Rock Ventures......»»

Merck & Co. shares slipped in the extended session Monday after the drug maker said that its lung-cancer drug Keytruda did not meet one of its endpoints in a clinical study. Merck shares declined 0......»»